Jack Truong, known for spearheading a series of high-profit corporate makeovers, reveals why taking an uncomfortable path often leads to success. By Exec Edge Editorial Staff As defined by Investopedia, disruptive innovation “transforms expensive or highly sophisticated products or services...

By Karen Roman Diagnostics company SkylineDx said it will present clinical data on the success of its Merlin test at the 21st International Congress of the Society for Melanoma Research 2024 in New Orleans. The CP-GEP Merlin test accurately stratifies...

Tech Edge hosted a fireside chat with Qualys, Inc. (Nasdaq: QLYS) to discuss the company’s 25th year anniversary, the launch of the Enterprise TruRisk Management platform, and more. The event featured Qualys’ President and CEO Sumedh Thakar, moderated by Exec...

By Daniella Parra Recordati said it will acquire the global rights to Enjaymo, used to treat a rare blood disorder, from Sanofi. Enjaymo has been approved by the FDA, European Commission, and Japan’s Ministry of Health, the company said. Recordati...

By Karen Roman Winemaker The Duckhorn Portfolio, Inc. (NYSE: NAPA) said it will be taken private in an all-cash deal worth $1.95 billion by Butterfly Equity, in a transaction expected to conclude this winter. The private equity firm agreed to...

By Karen Roman Eliem Therapeutics, Inc. (Nasdaq: ELYM) said its new corporate name will be Climb Bio, Inc. and it will start trading at Nasdaq with the ticker symbol “CLYM” on Oct. 3. This rebranding reflects Climb’s laser-focused mission on...

Republicans’ attempt to ban TikTok is a ‘self-own,’ says the former Trump staffer, whose TikTok stardom is a blueprint for how a new generation of voters – and consumers – can be influenced. By Exec Edge Editorial Staff John McEntee...

By Karen Roman Aktis Oncology said it raised $175 million in Series B financing, led by RA Capital Management, with RTW Investments and Janus Henderson Investors as co-leads. The capital will contribute to the company’s radiopharmaceuticals pipeline including AKY-1189, its...

By Daniella Parra Vivani Medical said it received regulatory approval in Australia for its GLP-1 (exenatide) implant, aimed at treating obese and overweight individuals. The trial will evaluate the safety, tolerability and pharmacokinetic profile of the implant, which is designed...

Tech Edge hosted a fireside chat on Sept. 12 at Nasdaq MarketSite with Erik Carlson, Chief Operating Officer at Notified. The in-person interview was joined by Editor-at-Large Jarrett Banks and they discussed the company’s partnership with CLEAR and its integration into the GlobeNewswire...